Home » Topics » Regulatory

Regulatory
RSS

FDA approves Cimzia for ankylosing spondylitis, issues complete response letter for axSpA

Oct. 21, 2013

No Comments

FDA approves Opsumit for PAH

Oct. 21, 2013

No Comments

FDA approves Novoeight for use in adults and children with hemophilia A

Oct. 17, 2013

No Comments

Duavee approved for vasomotor symptoms and preventing postmenopausal osteoporosis

Oct. 4, 2013

No Comments

Jublia approved in Canada for the treatment of onychomycosis

Oct. 4, 2013

No Comments

FDA grants accelerated approval of new indication for Perjeta

Oct. 2, 2013

No Comments

FDA approves vortioxetine for major depressive disorder

Oct. 1, 2013

No Comments

FDA approves Cimzia for treatment of active psoriatic arthritis

Oct. 1, 2013

No Comments

Simeprevir obtains first approval in Japan

Sep. 27, 2013

No Comments

First approval in Europe for Gilead Sciences' cobicistat

Sep. 26, 2013

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

FDA approves Cimzia for ankylosing spondylitis, issues complete response letter for axSpA

FDA approves Opsumit for PAH

FDA approves Novoeight for use in adults and children with hemophilia A

Duavee approved for vasomotor symptoms and preventing postmenopausal osteoporosis

Jublia approved in Canada for the treatment of onychomycosis

FDA grants accelerated approval of new indication for Perjeta

FDA approves vortioxetine for major depressive disorder

FDA approves Cimzia for treatment of active psoriatic arthritis

Simeprevir obtains first approval in Japan

First approval in Europe for Gilead Sciences' cobicistat

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Regulatory RSS

Regulatory
RSS